Klaus Gustav Strein
Director/Board Member at NOVIMMUNE SA
Klaus Gustav Strein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| NOVIMMUNE SA | Director/Board Member | - | - |
EngMab SARL
 EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Chairman | 31/12/2012 | - |
| Founder | 31/12/2012 | - | |
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Director/Board Member | - | - |
Career history of Klaus Gustav Strein
Former positions of Klaus Gustav Strein
| Companies | Position | Start | End |
|---|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 13/09/2011 | 13/09/2011 |
| Lamkap Bio Gamma AG | Chairman | - | - |
| Lamkap Bio Alpha AG | Chairman | - | - |
LamKap Bio beta AG
 LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Chairman | - | - |
| BB BIOTECH AG | Director/Board Member | 18/03/2013 | - |
Training of Klaus Gustav Strein
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistics
International
| Switzerland | 9 |
| Germany | 2 |
Operational
| Chairman | 4 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BB BIOTECH AG | Finance |
| ROCHE HOLDING AG | Health Technology |
| Private companies | 6 |
|---|---|
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
EngMab SARL
EngMab SARL Pharmaceuticals: MajorHealth Technology EngMab SARL operates as a biotechnology company. It focuses on cancer immunotherapy and hematological malignancies and solid tumors. The company was founded by Klaus Strein in 2013 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
LamKap Bio beta AG
LamKap Bio beta AG BiotechnologyHealth Technology LamKap Bio beta AG specializes in research and development. It also focuses on licensing and marketing of medical therapies, in particular antibody-based therapies against cancer and diseases of the immune system. The company was founded on December 12, 2017 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
| Lamkap Bio Alpha AG | |
| Lamkap Bio Gamma AG |
- Stock Market
- Insiders
- Klaus Gustav Strein
- Experience
